PATENT CLAIM ANALYSIS

Application Number: 15896273
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["544", "106000"]

Abstract:
3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol5-yl)methyl]-1,3-thiazolidine-2,4-dione methanesulphonate of formula (II): Medicinal products containing the same which are useful in treating cancer.

Claim (Index 2):
A process for obtaining the compound of formula (II) according to  claim 1 , wherein 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione is dissolved in a binary system of solvent/water, to which solution from 1 to 2 molar equivalents of methanesulphonic acid are added, stirring until the methanesulphonate precipitates out, which precipitate is filtered off.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.22581
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14904260', '13373016', '12806045', '13772984', '10835209']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8131003133969315
- 35 USC 102 Novelty (BERT): 0.587023651720217
- Combined Prediction Score: 0.7904926472292599
- Mean Citation Score: 359.568138
- Max Citation Score: 484.32306
- Similarity Product: 482.0369818184674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test